Boothe Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Boothe Investment Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-64,208	Closed	-$5.21M	–	44
2025 Q1	$5.21M	Buy	64,208 +366	+0.6%	+$32.7K	2.37%	19
2024 Q4	$5.75M	Buy	63,842 +18	+0%	+$1.74K	2.5%	18
2024 Q3	$6.31M	Sell	63,824 -861	-1%	-$84.6K	2.88%	15
2024 Q2	$6.02M	Buy	+64,685	New	+$5.8M	2.79%	15
2018 Q4	–	Sell	-29,111	Closed	-$2.79M	–	25
2018 Q3	$2.79M	Buy	29,111 +708	+2%	+$68.6K	2.6%	10
2018 Q2	$2.7M	Buy	+28,403	New	+$2.61M	2.53%	8

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boothe Investment Group's XBI Position: Q2 2025 in Review

Boothe Investment Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 64,208 shares — an estimated $5.21M sold.

Boothe Investment Group first reported a position in XBI in Q2 2018 and held it in 6 quarters. The position peaked at $6.31M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Boothe Investment Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Boothe Investment Group sold 64,208 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $5.21M.
Boothe Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 6 quarters.
Boothe Investment Group's State Street SPDR S&P Biotech ETF position peaked at $6.31M in Q3 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Boothe Investment Group's 13F filing for Q2 2025, filed 31 Jul 2025.